Artículos por temáticas

Targeting mitochondria-regulated ferroptosis: A new frontier in Parkinson's disease therapy

Wang W, Thomas ER, Xiao R, Chen T, Guo Q, Liu K, Yang Y, Li X.

Neuropharmacology. 2025 Aug 15;274:110439. doi: 10.1016/j.neuropharm.2025.110439. Epub 2025 Mar 31.

Iron mishandling in the brain and periphery in Parkinson's disease

Bolen ML, Menees KB, Dupreez AC, Tansey MG.

NPJ Parkinsons Dis. 2025 Aug 18;11(1):246. doi: 10.1038/s41531-025-01089-7.

Exosomes and Their miRNA as a Potential Biomarker in the Diagnosis of Parkinson's Disease

Vijayakumar S, Yesudhason BV, Anandharaj JL, Kalaivanan L, Selvan Christyraj JRS.

ACS Chem Neurosci. 2025 Aug 6;16(15):2756-2766. doi: 10.1021/acschemneuro.5c00313. Epub 2025 Jul 17.

Drug-Induced Parkinsonism or Parkinson's Disease: A Diagnostic Challenge in a Psychiatric Patient

Balcerzak W, Gorzkowska A, Konieczna M, Blach A, Lasek-Bal A.

Cureus. 2025 Jul 17;17(7):e88177. doi: 10.7759/cureus.88177. eCollection 2025 Jul.

Artificial Intelligence in Diagnosis and Prognosis of Cognitive Impairment in Parkinson's Disease

Moeinafshar A, Barati AR, Tehrani Fateh S, Pahlevan Fallahy MT, Soltani Khaboushan A.

Dement Geriatr Cogn Disord. 2025 Jul 3:1-34. doi: 10.1159/000547180. Online ahead of print.

Recent advances in fluid and tissue-based biomarkers for use in Parkinson's disease

Rajmohan R, Wen A, Henchcliffe C.

Expert Rev Neurother. 2025 Aug;25(8):951-958. doi: 10.1080/14737175.2025.2515068. Epub 2025 Jun 29.

The Small Intestinal Microbiota and the Gut-Brain Axis in Parkinson's Disease: A Narrative Review

Carrossa G, Misenti V, Faggin S, Giron MC, Antonini A.

Biomedicines. 2025 Jul 19;13(7):1769. doi: 10.3390/biomedicines13071769.

Prosaposin: A Multifaceted Protein Orchestrating Biological Processes and Diseases

Li X, Guo L.

Cells. 2025 Jul 22;14(15):1131. doi: 10.3390/cells14151131.

Netrin-1: Dual Roles in Neuroinflammation and Neurodegenerative Disease Dynamics

Farahani H, Ganji A, Mosayebi G, Monfared ME, Ghazavi A.

Int J Inflam. 2025 Jul 28;2025:8670048. doi: 10.1155/ijin/8670048. eCollection 2025.

Challenges in studying air pollution to neurodegenerative diseases

Kwon D, Paul KC, O'Sharkey K, Paik SA, Yu Y, Bronstein JM, Ritz B.

Environ Res. 2025 Aug 1;278:121597. doi: 10.1016/j.envres.2025.121597. Epub 2025 Apr 11.

Restless legs syndrome in Parkinson's disease: epidemiology, pathogenetic overlaps, and clinical management

Wang Z, Zhang S, Li J, Liu H, Hu X, Yu Q, Kuang G, Liu L, Zhang H, Yu D, Xiong N.

J Neurol. 2025 Aug 11;272(9):567. doi: 10.1007/s00415-025-13288-6.

The relationship between kidney health and neurodegenerative diseases

Zuo M, Chang L, Neale N, Maameri L, Gawhary S, Lona-Durazo F, Gagliano Taliun SA.

Brain. 2025 Aug 1;148(8):2616-2630. doi: 10.1093/brain/awaf113.

Parkinson's disease and gut microbiota metabolites: The dual impact of vitamins and functional amyloids

Mirab F, Pirhaghi M, Otzen DE, Saboury AA.

Biochim Biophys Acta Mol Basis Dis. 2025 Aug;1871(6):167862. doi: 10.1016/j.bbadis.2025.167862. Epub 2025 Apr 18.

Patient, target, device, and program selection for DBS in Parkinson's disease: advancing toward precision care

Wagle Shukla A, Bange M, Muthuraman M.

NPJ Parkinsons Dis. 2025 Jul 1;11(1):195. doi: 10.1038/s41531-025-01015-x.

The Treatment of Older Patients with Parkinson's Disease

Djukic M, Yoshida-Stiksrud E, Nau R.

Dtsch Arztebl Int. 2025 Jul 5;122(15):412-418. doi: 10.3238/arztebl.m2025.0083.